BMRN insider transaction filings
BIOMARIN PHARMACEUTICAL INC — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-04. Screen BMRN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-04 | 4 | Countouriotis Athena — Director | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-06-04 | 4 | Walbert Timothy P — Director | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-06-04 | 4 | Ho Maykin — Director | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-06-04 | 4 | HOMBACH ROBERT J. — Director | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-06-04 | 4 | Enyedy Mark J — Director | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-06-04 | 4 | Dere Willard H — Director | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-06-04 | 4 | CLARK IAN T — Director | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-06-04 | 4 | Bodem Barbara W. — Director | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-06-04 | 4 | ANDERSON ELIZABETH M — Director | Grant/award (A): 7,490 @ $0 | EDGAR |
| 2026-05-21 | 4 | Hubbard Cristin — EVP, Chief Commercial Officer | Tax withholding (F): 2,318 @ $50.20 | EDGAR |
| 2026-05-11 | 4 | Friberg Gregory R — EVP, Chief R&D Officer | Sale (S): 3,281 @ $53.85 | EDGAR |
| 2026-03-19 | 4 | Davis George Eric — EVP, Chief Legal Officer | Tax withholding (F): 1,273 @ $56.05 | EDGAR |
| 2026-03-19 | 4 | Guyer Charles Greg — EVP, Chief Technical Officer | Tax withholding (F): 1,693 @ $56.05 | EDGAR |
| 2026-03-19 | 4 | Mueller Brian — EVP, Chief Financial Officer | Tax withholding (F): 2,117 @ $56.05 | EDGAR |
| 2026-03-19 | 4 | Hardy Alexander — Chief Executive Officer, Director | Tax withholding (F): 4,252 @ $56.05 | EDGAR |
| 2026-03-18 | 4 | Hubbard Cristin — EVP, Chief Commercial Officer | Grant/award (A): 15,410 @ $0 · Tax withholding (F): 1,245 @ $56.05 · Grant/award (A): 36,680 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | Friberg Gregory R — EVP, Chief R&D Officer | Grant/award (A): 19,150 @ $0 · Tax withholding (F): 1,629 @ $56.05 · Grant/award (A): 45,600 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Guyer Charles Greg — EVP, Chief Technical Officer | Tax withholding (F): 9,109 @ $58.51 · Grant/award (A): 14,990 @ $0 · Grant/award (A): 35,680 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Davis George Eric — EVP, Chief Legal Officer | Tax withholding (F): 7,177 @ $58.51 · Grant/award (A): 14,570 @ $0 · Grant/award (A): 34,690 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Mueller Brian — EVP, Chief Financial Officer | Tax withholding (F): 9,945 @ $58.51 · Grant/award (A): 18,740 @ $0 · Grant/award (A): 44,600 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Hardy Alexander — Chief Executive Officer, Director | Tax withholding (F): 2,941 @ $58.51 · Grant/award (A): 62,440 @ $0 · Grant/award (A): 89,200 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Guyer Charles Greg — EVP, Chief Technical Officer | Sale (S): 16,486 @ $60.46 | EDGAR |
| 2026-02-26 | 4 | Davis George Eric — EVP, Chief Legal Officer | Grant/award (A): 6,177 @ $0 · Grant/award (A): 6,675 @ $0 · Grant/award (A): 2,372 @ $0 · Sale (S): 26,061 @ $61.36 | EDGAR |
| 2026-02-26 | 4 | Guyer Charles Greg — EVP, Chief Technical Officer | Grant/award (A): 6,176 @ $0 · Grant/award (A): 6,675 @ $0 · Grant/award (A): 2,371 @ $0 | EDGAR |
| 2026-02-26 | 4 | Friberg Gregory R — EVP, Chief R&D Officer | Sale (S): 6,326 @ $60.38 | EDGAR |
| 2026-02-26 | 4 | Mueller Brian — EVP, Chief Financial Officer | Grant/award (A): 6,683 @ $0 · Grant/award (A): 7,230 @ $0 · Grant/award (A): 2,569 @ $0 | EDGAR |
| 2026-01-22 | 4 | Ramchandani Rashmi Virendra — VP, Chief Accounting Officer | Grant/award (A): 18,540 @ $0 · Grant/award (A): 7,070 @ $0 · Grant/award (A): 18,220 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | Hardy Alexander — Chief Executive Officer, Director | Grant/award (A): 375 @ $54.14 · Tax withholding (F): 16,570 @ $55.03 | EDGAR |
| 2025-10-02 | 4 | Friberg Gregory R — EVP, Chief R&D Officer | Tax withholding (F): 3,304 @ $54.16 | EDGAR |
| 2025-08-05 | 4 | CLARK IAN T — Director | Grant/award (A): 7,000 @ $0 | EDGAR |
| 2025-05-22 | 4 | Hubbard Cristin — EVP, Chief Commercial Officer | Tax withholding (F): 2,155 @ $59.93 | EDGAR |
| 2025-05-22 | 4 | Walbert Timothy P — Director | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-05-22 | 4 | MEIER RICHARD A — Director | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-05-22 | 4 | HOMBACH ROBERT J. — Director | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-05-22 | 4 | Ho Maykin — Director | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-05-22 | 4 | Enyedy Mark J — Director | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-05-22 | 4 | Dere Willard H — Director | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-05-22 | 4 | Countouriotis Athena — Director | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-05-22 | 4 | Bodem Barbara W. — Director | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-05-22 | 4 | ANDERSON ELIZABETH M — Director | Grant/award (A): 6,650 @ $0 | EDGAR |
| 2025-05-20 | 4 | Burkhart Erin — GVP, Chief Accounting Officer | Tax withholding (F): 996 @ $59.27 · Sale (S): 1,786 @ $59.31 | EDGAR |
| 2025-05-06 | 4 | Hubbard Cristin — EVP, Chief Commercial Officer | Grant/award (A): 273 @ $54.14 · Sale (S): 273 @ $64.92 | EDGAR |
| 2025-03-20 | 4 | Burkhart Erin — GVP, Chief Accounting Officer | Sale (S): 1,295 @ $71.52 | EDGAR |
| 2025-03-18 | 4 | Burkhart Erin — GVP, Chief Accounting Officer | Tax withholding (F): 823 @ $69.44 · Grant/award (A): 5,970 @ $0 · Grant/award (A): 9,230 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Davis George Eric — EVP, Chief Legal Officer | Tax withholding (F): 16,249 @ $69.44 · Grant/award (A): 12,940 @ $0 · Grant/award (A): 30,020 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Hubbard Cristin — EVP, Chief Commercial Officer | Grant/award (A): 13,310 @ $0 · Grant/award (A): 30,880 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Friberg Gregory R — EVP, Chief R&D Officer | Grant/award (A): 17,750 @ $0 · Grant/award (A): 41,170 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Guyer Charles Greg — EVP, Chief Technical Officer | Tax withholding (F): 20,127 @ $69.44 · Grant/award (A): 13,310 @ $0 · Grant/award (A): 30,880 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Mueller Brian — EVP, Chief Financial Officer | Tax withholding (F): 18,497 @ $69.44 · Grant/award (A): 16,640 @ $0 · Grant/award (A): 38,590 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Hardy Alexander — Chief Executive Officer, Director | Tax withholding (F): 2,933 @ $69.44 · Grant/award (A): 44,360 @ $0 · Grant/award (A): 61,750 (derivative) @ $0 | EDGAR |
Recent 8-K events — BIOMARIN PHARMACEUTICAL INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-13 | 8-K/A | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-02-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BMRN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →